Alkahest, a subsidiary of Grifols, is developing therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline -- key medical challenges of our generation. The company’s breakthrough research has demonstrated that factors in blood plasma of young mice are able to reverse brain deficits in normal aging and Alzheimer’s disease models in mice. Clinical studies are being conducted in patients with different types of dementia and other neurodegenerative diseases. Alkahest is based in San Carlos, Calif., while Grifols, a global healthcare company, is headquartered in Barcelona, Spain.
Company Details
- Employees
- 43
- Founded
- -
- Address
- 125 Shoreway Drive,
- Phone
- 650-801-0474
- in****@****est.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- alkahest.com
- HQ
- San Carlos, California
Alkahest, Inc. Questions
Alkahest, Inc.'s helpline number is 650-801-0474
Alkahest, Inc.'s website is alkahest.com
Alkahest, Inc.'s LinkedIn profile is https://www.linkedin.com/company/alkahest-inc-
Alkahest, Inc. has
43 employees.
View email and phone details for 43
employees at Alkahest, Inc..
Alkahest, Inc.'s industry is
Biotechnology Research
Alkahest, Inc.'s top competitors are
Unity Biotechnology,
Teal Omics,
Gigagen Inc,
Galapagos,
Allakos Inc,
Sonic Manufacturing Technologies,
Grifols,
Elevian, Inc.,
Arda Therapeutics,
Genentech.
Alkahest, Inc.'s support email address is info@alkahest.com
Alkahest, Inc.'s categories are Biotechnology Research
Alkahest, Inc.'s founding year is 2014
